- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 323/48 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to nitrogen atoms
Patent holdings for IPC class C07C 323/48
Total number of patents in this class: 16
10-year publication summary
1
|
1
|
3
|
2
|
0
|
0
|
3
|
0
|
0
|
0
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Pfizer Inc. | 3379 |
2 |
The United States of America as represented by the Secretary of the Air Force | 840 |
2 |
London Pharmaceuticals and Research Corporation | 27 |
2 |
BASF SE | 20892 |
1 |
Bayer Cropscience AG | 2051 |
1 |
Boe Technology Group Co., Ltd. | 40814 |
1 |
Cellix Bio Private Limited | 52 |
1 |
Creative Therapeutics GmbH | 5 |
1 |
Daito Chemix Corporation | 11 |
1 |
Ligand Pharmaceuticals Incorporated | 166 |
1 |
Ustav Organicke Chemie a Biochemie AV CR, V.v.i. | 124 |
1 |
Wyeth | 380 |
1 |
CF Plus Chemicals s.r.o. | 4 |
1 |
Other owners | 0 |